Paid Clinical Trials in Minnesota

Minnesota has 2,231 paid clinical trials enrolling now across cities including Rochester, Minneapolis and Saint Paul. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Minnesota include Mayo Clinic and University of Minnesota Medical Center, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,939 clinical trials

Get a weekly email when new trials open in Rochester, MN.

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

for Stargardt Disease

Sites in Rochester +6 more locations

Sponsor: AAVantgarde Bio Srl

Sex: All·Age: 8 - 55

Code: NCT07161544·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

for Non-Small Cell Lung Cancer

Sites in Minneapolis +4 more locations

Sponsor: Fate Therapeutics

Sex: All·Age: 18+

Code: NCT07216105·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

for Advanced Pheochromocytoma and Paraganglioma

Sites in Rochester +8 more locations

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07282587·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

for Prurigo Nodularis (PN)

Sites in New Brighton +9 more locations

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All·Age: 18 - 75

Code: NCT07236099·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

for Renal Impairment

Sites in Saint Paul +3 more locations

Sponsor: Pfizer

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT07315360·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Clinical Course Of Disease In Participants With FA-CM

for Friedreich Ataxia

Sites in Rochester +7 more locations

Sponsor: Lexeo Therapeutics

Sex: All·Age: 6+

Code: NCT06865482·Recruiting·Listed Mar 2025

Apply to this trial

A Study of CTD402 in T-ALL/LBL Patients

for Acute Lymphocytic Leukemia Refractory

Sites in Rochester +6 more locations

Sponsor: Imviva Bio

Sex: All·Age: 1+

Code: NCT07070219·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

for Von Willebrand Disease, Type 3

Sites in Minneapolis +5 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 1 Month+

Code: NCT06998524·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

for Catecholaminergic Polymorphic Ventricular Tachycardia

Sites in Rochester +3 more locations

Sponsor: Solid Biosciences Inc.

Sex: All·Age: 7+

Code: NCT07148089·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

for Breast Cancer

Sites in Rochester +3 more locations

Sponsor: Cellectar Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07311993·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for Esophageal Squamous Cell Carcinoma

Sites in Rochester +12 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06644781·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

for Clostridioides Difficile Infection Recurrence

Sites in Rochester +3 more locations

Sponsor: Bactolife A/S

Sex: All·Age: 18+

Code: NCT07250724·Recruiting·Listed Nov 2025

Apply to this trial

Actinium Therapy for Late-stage Aggressive Sarcomas

for Advanced Soft Tissue Sarcoma

Sites in Rochester +4 more locations

Sponsor: Ratio Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07156565·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for Congenital Adrenal Hyperplasia

Sites in Minneapolis +8 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 1 - 17

Code: NCT07159841·Phase 2, Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

for Resistant Hypertension

Sites in Rochester +5 more locations

Sponsor: DeepQure Inc.

Sex: All·Age: 22 - 80

Code: NCT06526858·Recruiting·Listed Jul 2024

Apply to this trial

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

for Weight Regain

Sites in Rochester +8 more locations

Sponsor: Boston Scientific Corporation

Sex: All·Age: 18+

Code: NCT07015424·Recruiting·Listed Jun 2025

Apply to this trial

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Sites in Minneapolis +7 more locations

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07140900·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

for Relapsing Remitting Multiple Sclerosis

Sites in Plymouth +8 more locations

Sponsor: SetPoint Medical Corporation

Sex: All·Age: 22 - 60

Code: NCT06796504·Recruiting·Listed Jan 2025

Apply to this trial

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

for Low-grade Upper Tract Urothelial Carcinoma

Drug: Nadofaragene Firadenovec

Sites in Rochester +8 more locations

Sponsor: Ferring Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06668493·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Perform Humeral System Study

for Osteoarthritis Shoulder

Sites in Eagan +4 more locations

Sponsor: Stryker Trauma and Extremities

Sex: All·Age: 18+

Code: NCT05067543·Recruiting·Listed Oct 2021

Apply to this trial

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

for Congenital Adrenal Hyperplasia

Sites in Rochester, Minneapolis +11 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT07144163·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

for Immunoglobulin A Nephropathy (IgAN)

Sites in Edina +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07146906·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

AERA Pediatrics Registry

for Dysfunction of Eustachian Tube

Sites in Minneapolis +8 more locations

Sponsor: Integra LifeSciences Corporation

Sex: All·Age: Up to 18

Code: NCT07071298·Recruiting·Listed Jul 2025

Apply to this trial

AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

for Phenylketonurias

Sites in Minneapolis +4 more locations

Sponsor: NGGT INC.

Sex: All·Age: 18 - 55

Code: NCT06332807·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness

for Pulmonary Embolism Acute

Sites in Saint Cloud +5 more locations

Sponsor: Angiodynamics, Inc.

Sex: All·Age: 18+

Code: NCT07280247·Recruiting·Listed Dec 2025

Apply to this trial

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

for Leadless Pacemaker

Sites in Rochester +9 more locations

Sponsor: Biotronik, Inc.

Sex: All·Age: 18+

Code: NCT07118358·Recruiting·Listed Aug 2025

Apply to this trial

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

for Refractory Angina

Sites in Minneapolis +13 more locations

Sponsor: XyloCor Therapeutics, Inc.

Sex: All·Age: 18 - 85

Code: NCT07048808·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

for Epithelial Ovarian Cancer

Sites in Minneapolis +7 more locations

Sponsor: Imunon

Sex: Female·Age: 18+

Code: NCT06915025·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for B-cell Acute Lymphoblastic Leukemia

Sites in Rochester +10 more locations

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All·Age: 13 - 90

Code: NCT06533579·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

for Prostate Cancer (Adenocarcinoma)

Sites in Minneapolis +6 more locations

Sponsor: Acerand Therapeutics (Hong Kong) Limited

Sex: Male·Age: 18+

Code: NCT06801236·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

for Non Small Cell Lung Cancer

Sites in Rochester +9 more locations

Sponsor: Ankyra Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT07027514·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

for Niemann-Pick Type C Disease

Sites in Rochester, Minneapolis +3 more locations

Sponsor: Azafaros B.V.

Sex: All·Age: 4+

Code: NCT07082725·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

for Leukemia, Myelomonocytic, Chronic

Drug: Pacritinib

Sites in Rochester +3 more locations

Sponsor: Theradex

Sex: All·Age: 18+

Code: NCT07033598·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

for X-linked Retinoschisis

Sites in Rochester +17 more locations

Sponsor: Atsena Therapeutics Inc.

Sex: All·Age: 6+

Code: NCT05878860·Phase 3·Recruiting·Listed May 2023

Apply to this trial

A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

for Fabry Disease

Sites in Minneapolis +5 more locations

Sponsor: Amicus Therapeutics

Sex: All·Age: 2 - 11

Code: NCT06904261·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Drug: Mosunetuzumab

Sites in Rochester +2 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT05091424·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for Niemann-Pick Type C Disease

Sites in Rochester, Minneapolis +3 more locations

Sponsor: Azafaros B.V.

Sex: All·Age: 4+

Code: NCT07054515·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Safety of HRX215 in Patients After Minor and Major Liver Resection

for Liver Resection

Sites in Rochester +3 more locations

Sponsor: HepaRegeniX GmbH

Sex: All·Age: 18 - 75

Code: NCT06638502·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

The TRICURE EFS Study

for Tricuspid Valve Regurgitation

Sites in Minneapolis +7 more locations

Sponsor: TRiCares

Sex: All·Age: 18+

Code: NCT06506942·Recruiting·Listed Jul 2024

Apply to this trial

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

for Tricuspid Regurgitation

Sites in Rochester +9 more locations

Sponsor: Laplace Interventional, Inc

Sex: All·Age: 18 - 90

Code: NCT06183684·Recruiting·Listed Dec 2023

Apply to this trial